COST-EFFECTIVENESS OF ROSIGLITAZONE COMBINATION THERAPY FOR THE TREATMENT OF TYPE 2 DIABETES IN THE CZECH REPUBLIC

T. Dolezal, J. Skoupa, M. J. Taylor, S. Whitehead, Missing Rausova, P. Pavlikova

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)A504-A504
Number of pages1
JournalValue in Health
Volume11
Issue number6
Publication statusPublished - Nov 2008

Cite this